Clinical Significance of Serum Ornithine Carbamoyltransferase in Liver Diseases – Is the Ratio of OCT/ALT a New Tumor Marker? | Zendy

Katsutoshi Tokushige | Zendy; Etsuko Hashimoto | Zendy; Noriko Matsushita | Zendy; Nobuyuki Torii | Zendy; Makiko Taniai | Zendy; Keiko Shiratori | Zendy; Hiroshi Maruyam | Zendy

Open Access

Clinical Significance of Serum Ornithine Carbamoyltransferase in Liver Diseases – Is the Ratio of OCT/ALT a New Tumor Marker?

Author(s) -

Katsutoshi Tokushige,

Etsuko Hashimoto,

Noriko Matsushita,

Nobuyuki Torii,

Makiko Taniai,

Keiko Shiratori,

Hiroshi Maruyam

Publication year - 2012

Publication title -

intech ebooks

Language(s) - English

Resource type - Book series

DOI - 10.5772/29259

Subject(s) - ornithine carbamoyltransferase , pathology , tumor marker , clinical significance , medicine , biology , ornithine , genetics , cancer , amino acid , arginine

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most common cause of cancer-related mortality (World Health Organization. Mortality database, 2010). According to the most recent nationwide Japanese registration data, primary liver cancer ranks fourth for men and sixth for women as cause of death from malignant neoplasm (Journal of Health and Welfare Statistics. Health and Welfare Statistics Association, 2009).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research